We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
MainStreet Bancshares
MNSB
$172M
| $353K | ﹤0.01% |
14,729
+1,019
| +7% | +$24K |
|
777
Acadia Healthcare
ACHC
$2.94B
| $352K | ﹤0.01% |
5,501
+159
| +3% | +$10K |
|
778
Monro
MNRO
$398M
| $352K | ﹤0.01% |
6,114
-70
| -1% | -$4.11K |
|
|
MZTI
779
The Marzetti Company
MZTI
$3.11B
| $351K | ﹤0.01% |
2,085
+125
| +6% | +$23.1K |
|
780
Tetra Tech
TTEK
$9.07B
| $350K | ﹤0.01% |
11,715
-1,195
| -9% | -$32.8K |
|
781
Brunswick
BC
$5.28B
| $349K | ﹤0.01% |
3,672
-443
| -11% | -$44.1K |
|
782
KB Financial Group
KB
$43.5B
| $349K | ﹤0.01% |
7,516
+394
| +6% | +$17.8K |
|
783
AGNC Investment
AGNC
$12.9B
| $346K | ﹤0.01% |
21,823
+838
| +4% | +$13.6K |
|
784
Mid-America Apartment Communities
MAA
$15.7B
| $346K | ﹤0.01% |
+1,859
| New | +$349K |
|
785
National Grid
NGG
$81.3B
| $346K | ﹤0.01% |
6,552
+852
| +15% | +$48.9K |
|
786
LyondellBasell Industries
LYB
$19.2B
| $344K | ﹤0.01% |
3,665
+701
| +24% | +$68.8K |
|
787
Raymond James Financial
RJF
$34B
| $344K | ﹤0.01% |
3,717
+475
| +15% | +$42.5K |
|
788
Encompass Health
EHC
$12.4B
| $343K | ﹤0.01% |
5,722
+8
| +0.1% | +$503 |
|
|
LOGC
789
DELISTED
ContextLogic
LOGC
| $343K | ﹤0.01% |
2,100
-389
| -16% | -$96.8K |
|
|
MIME
790
DELISTED
Mimecast Limited
MIME
| $343K | ﹤0.01% |
5,403
-211
| -4% | -$12.9K |
|
791
Ball Corp
BALL
$16.8B
| $342K | ﹤0.01% |
+3,798
| New | +$337K |
|
792
Blue Bird Corp
BLBD
$2.18B
| $340K | ﹤0.01% |
16,319
+4,950
| +44% | +$110K |
|
793
Ametek
AME
$58.2B
| $338K | ﹤0.01% |
2,727
+184
| +7% | +$24.7K |
|
794
Fox Factory Holding Corp
FOXF
$886M
| $338K | ﹤0.01% |
2,337
+14
| +0.6% | +$2.15K |
|
|
ZNGA
795
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $338K | ﹤0.01% |
44,875
+15,642
| +54% | +$142K |
|
796
Twist Bioscience
TWST
$7.25B
| $336K | ﹤0.01% |
3,142
+120
| +4% | +$13.7K |
|
797
Boston Scientific
BSX
$71.5B
| $335K | ﹤0.01% |
7,704
+1,397
| +22% | +$61.8K |
|
|
HIO
798
Western Asset High Income Opportunity Fund
HIO
$340M
| $335K | ﹤0.01% |
64,174
+20,000
| +45% | +$105K |
|
799
Nasdaq
NDAQ
$52.9B
| $334K | ﹤0.01% |
5,184
+1,371
| +36% | +$86.3K |
|
800
Beam Therapeutics
BEAM
$2.84B
| $333K | ﹤0.01% |
3,823
| – | – |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.